Future Journal of Pharmaceutical Sciences

Table 9 % Recovery of Ivacaftor in human plasma

From: A rapid RP-HPLC method for the simultaneous estimation of Ivacaftor and Tezacaftor and in silico study of their metabolitic products

S. no.	% Level	Conc added (μg/mL)	% Recovery	Average %	S.D	% RSD
1	50%	22.5	97.46	97.44	0.001	0.002
2			97.4
3			97.42
4	100%	45	103.35	103.5	0.10	0.11
5			104.06
6			103.37
7	150%	67.5	98.59	98.04	0.28	0.25
8			98.31
9			97.22

Back to article page